Scarica l'app Stockscreener
8.92
1.87%
-0.17
Precedente Chiudi:
$9.09
Aprire:
$9.1
Volume 24 ore:
131.90K
Relative Volume:
1.03
Capitalizzazione di mercato:
$242.91M
Reddito:
$50.51M
Utile/perdita netta:
$-29.63M
Rapporto P/E:
-7.7843
EPS:
-1.1459
Flusso di cassa netto:
-
1 W Prestazione:
-1.65%
1M Prestazione:
-8.32%
6M Prestazione:
-26.28%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$8.805
$9.295
Intervallo di 1 settimana:
$8.50
$9.60
Portata 52W:
$8.50
$17.19
Carlsmed Inc Stock (CARL) Company Profile
Nome
Carlsmed Inc
Settore
Industria
Telefono
858-295-9290
Indirizzo
1800 ASTON AVENUE, CARLSBAD
Compare CARL vs VEEV, BTSG, TEM, HQY, DOCS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
8.92 | 247.54M | 50.51M | -29.63M | 0 | -1.1459 |
VEEV
Veeva Systems Inc
|
171.19 | 27.80B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
51.44 | 10.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
54.07 | 10.01B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.63 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.77 | 4.60B | 637.78M | 239.40M | 307.21M | 1.1909 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-18 | Iniziato | BTIG Research | Buy |
| 2025-08-18 | Iniziato | BofA Securities | Buy |
| 2025-08-18 | Iniziato | Goldman | Buy |
| 2025-08-18 | Iniziato | Piper Sandler | Overweight |
| 2025-08-18 | Iniziato | Truist | Buy |
Carlsmed Inc Borsa (CARL) Ultime notizie
Carlsmed Earnings Call Highlights Growth, Rising Costs - TipRanks
Carlsmed Q1 Earnings Call Highlights - Yahoo Finance
Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Carlsmed (CARL) Q1 2026 Earnings Transcript - The Globe and Mail
Earnings call transcript: Carlsmed Q1 2026 shows strong revenue growth - Investing.com
Carlsmed (NASDAQ:CARL) Shares Surge on Q1 Earnings Beat and Raised Full-Year Guidance - ChartMill
Carlsmed® Reports First Quarter 2026 Financial Results - The Manila Times
Top Carlsmed (CARL) Competitors 2026 - MarketBeat
Carlsmed Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
Carlsmed, Inc. (NASDAQ:CARL) Sees Large Drop in Short Interest - MarketBeat
Carlsmed, Inc. To Participate in Upcoming Investor Conferences - The Manila Times
Carlsmed (CARL) Stock Outlook | Q4 2025: Profit Exceeds ViewsInvestment Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Carlsmed (CARL) Stock: Why Market Expansion (Slight Loss) 2026-04-16Trending Volume Leaders - UBND thành phố Hải Phòng
Carlsmed, Inc. (NASDAQ:CARL) Short Interest Up 23.4% in March - MarketBeat
BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Maintains Target Price $23 - 富途牛牛
CARL Maintains Buy Rating -- Price Target Lowered to $18.00 by T - GuruFocus
Carlsmed (NASDAQ:CARL) Price Target Cut to $18.00 by Analysts at Truist Financial - MarketBeat
Truist Financial Maintains Carlsmed(CARL.US) With Buy Rating, Cuts Target Price to $18 - 富途牛牛
BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Cuts Target Price to $23 - 富途牛牛
Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026 - The Manila Times
Carlsmed Showcases Personalized Spine Fusion Gains, Cervical Expansion and Medicare Tailwinds at Needham Conf - Yahoo Finance
The Goldman Sachs Group Has Lowered Expectations for Carlsmed (NASDAQ:CARL) Stock Price - Defense World
Carlsmed (CARL) Analyst Rating: Goldman Sachs Lowers Price Targe - GuruFocus
Carlsmed (NASDAQ:CARL) Price Target Lowered to $17.00 at The Goldman Sachs Group - MarketBeat
CARL.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CARL.O PE Ratio & Valuation, Is CARL.O Overvalued - Intellectia AI
CARL Technical Analysis & Stock Price Forecast - Intellectia AI
CARL News & Events - Intellectia AI
Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference - The Manila Times
CARL Stock Analysis: Carlsmed Inc medical tech gains 6.41 percent trading at 9.63 - Cổng thông tin điện tử tỉnh Lào Cai
Carlsmed (NASDAQ:CARL) Upgraded at Zacks Research - Defense World
Carlsmed (NASDAQ:CARL) Upgraded by Zacks Research to Hold Rating - MarketBeat
Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Hold" from Analysts - MarketBeat
Carlsmed reports Q4, FY 2025 revenue above estimate - MSN
Carlsmed, Inc.: Fundamental Analysis and Financial Ratings | I82 | US14280C1053 - marketscreener.com
Carlsmed Poised for Positive Growth Trajectory - San Diego Business Journal
Carlsmed joins Russell 2000 Index following Q3 IPO - MSN
Head-To-Head Comparison: Carlsmed (CARL) vs. Its Rivals - Defense World
Comparing Carlsmed (CARL) & The Competition - Defense World
Head to Head Review: Carlsmed (CARL) and The Competition - Defense World
Carlsmed Earnings Call Highlights Rapid Growth, Rising Costs - TipRanks
Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish - MSN
Carlsmed (CARL) versus The Competition Head to Head Analysis - Defense World
Carlsmed unveils custom cervical plating tech - MSN
Carlsmed (CARL) vs. Its Peers Financial Survey - Defense World
Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference - Defense World
Carlsmed Inc Azioni (CARL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.66%
1.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):